These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 31866504)
1. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo. Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504 [TBL] [Abstract][Full Text] [Related]
2. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo. Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141 [TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
4. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264 [TBL] [Abstract][Full Text] [Related]
5. Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes. Höbel S; Loos A; Appelhans D; Schwarz S; Seidel J; Voit B; Aigner A J Control Release; 2011 Jan; 149(2):146-58. PubMed ID: 20946922 [TBL] [Abstract][Full Text] [Related]
6. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413 [TBL] [Abstract][Full Text] [Related]
7. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model. Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279 [TBL] [Abstract][Full Text] [Related]
8. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma. Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711 [TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo. Karimov M; Schulz M; Kahl T; Noske S; Kubczak M; Gockel I; Thieme R; Büch T; Reinert A; Ionov M; Bryszewska M; Franke H; Krügel U; Ewe A; Aigner A Nanomedicine; 2021 Aug; 36():102403. PubMed ID: 33932594 [TBL] [Abstract][Full Text] [Related]
12. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo. Höbel S; Aigner A Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558 [TBL] [Abstract][Full Text] [Related]